349
Participants
Start Date
March 1, 2011
Primary Completion Date
June 1, 2012
Study Completion Date
June 14, 2012
GSK 573719 +GW642444 125/25
125mcg/ 25mcg
GSK573719 + GW642444 62.5/25
62.5mcg/25mcg
GSK 573719 125
125mcg
GSK 573719 62.5
62.5mcg
GW642444 25
25mcg
Plb
Comparator
GSK Investigational Site, Sofia
GSK Investigational Site, Plovdiv
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Albany
GSK Investigational Site, Tallinn
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Großhansdorf
GSK Investigational Site, Richmond
GSK Investigational Site, Spartanburg
GSK Investigational Site, Gaffney
GSK Investigational Site, Union
GSK Investigational Site, Greenville
GSK Investigational Site, Solingen
GSK Investigational Site, Columbus
GSK Investigational Site, Bochum
GSK Investigational Site, Tartu
GSK Investigational Site, Witten
GSK Investigational Site, Gelnhausen
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Kingwood
GSK Investigational Site, Phoenix
GSK Investigational Site, Medford
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Lebanon
GSK Investigational Site, Barnaul
GSK Investigational Site, Moscow
GSK Investigational Site, Northwood
Lead Sponsor
GlaxoSmithKline
INDUSTRY